Anthrax as a Bioweapon
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What do sheep, Islamic fascists and Vladimir Putin have in common? Anthrax. The "poor man’s" weapon of mass destruction, this disease has been recognized since Biblical times. Join our guest, Dr. Nicholas Bergman has his discusses the development of anthrax into a weapon of mass destruction. Dr. Bergman received his PhD in biochemistry and molecular biology at the Massachusetts Institute of Technology. He is currently an Assistant Professor in the School of Biology at the Georgia Institute of Technology in Atlanta. He has published a paper examining some of the genomic properties of Anthrax in the Journal of Bacteriology.
Overview
What do sheep, Islamic fascists and Vladimir Putin have in common? Anthrax. The "poor man’s" weapon of mass destruction, this disease has been recognized since Biblical times. Join our guest, Dr. Nicholas Bergman has his discusses the development of anthrax into a weapon of mass destruction. Dr. Bergman received his PhD in biochemistry and molecular biology at the Massachusetts Institute of Technology. He is currently an Assistant Professor in the School of Biology at the Georgia Institute of Technology in Atlanta. He has published a paper examining some of the genomic properties of Anthrax in the Journal of Bacteriology.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Level Up Your Skills: Tailoring Management of HF
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?